Stay Updated
Press Releases
Statement from Patients For Affordable Drugs on Novartis' Drug Price
WASHINGTON, DC — The following statement was issued by David Mitchell, Founder and President of Patients For Affordable Drugs, regarding Novartis’ decision to price its CAR-T drug, Kymriah, at $475,000 per treatment. “As a cancer patient, the potential of CAR-T is exciting and I applaud FDA’s approval. It means hope for hundreds of children and […]
Press Releases
Patients For Affordable Drugs Launches Campaign Demanding Fair Pricing of New Novartis Cancer Drug
WASHINGTON, DC – Patients for Affordable Drugs launched a national campaign today to demand pharmaceutical giant Novartis price its new cancer drug fairly and in accordance with the fact that American taxpayers invested over $200 million to help discover the drug. In a letter to the CEO of Novartis, Patients For Affordable Drugs requested a […]
Press Releases
Patients For Affordable Drugs Urges FDA to Stop Abuses by Drug Corporations
WASHINGTON, DC – Patients For Affordable Drugs President and founder David Mitchell will urge the Food and Drug Administration (FDA) to take action to boost generic competition and help fix out-of-control drug prices. At a public meeting today, Mitchell will share his story about how the out-of-pocket cost for Revlimid, a cancer drug he took […]
Press Releases
Cancer Patient Sues Big Pharma for Illegal Price Gouging
WASHINGTON, DC – A patient with incurable blood cancer filed a class action lawsuit against Celgene Corporation for abusing consumer safety rules and maintaining a monopoly over its high-cost cancer drugs. The suit alleges Celgene illegally blocked generic development for its highly effective drugs Thalomid and Revlimid—the latter of which costs more than $12,000 for […]
Press Releases
Patients For Affordable Drugs Goes Inside the Belly of the Beast
June 8, 2017 Contact: [email protected] BOSTON, MA – Patients For Affordable Drugs is taking the fight for lower drug prices inside one of America’s biggest drug corporations. Today, Juliana Keeping, the mother of a cystic fibrosis child is headed to Vertex Pharmaceuticals’ annual shareholder meeting to confront company executives about their price gouging tactics and […]
Press Releases
Patients For Affordable Drugs Launches Petition to Lower Drug Prices
April 11, 2017 Contact: [email protected] WASHINGTON, D.C. – Today, Patients For Affordable Drugs launched a nationwide petition urging lawmakers to allow Medicare to negotiate lower drug prices on behalf of patients and taxpayers. The petition was launched by David Mitchell, a patient with incurable blood cancer whose drugs cost $20,000 per bi-weekly treatment. The petition […]
Press Releases
Patients For Affordable Drugs Co-Founder Testified Before Congress on Drug Prices
Watch the entire hearing below, or go to 25:56 for Mitchell’s testimony.
Press Releases
Statement on Prescription Drug Importation Legislation
February 28, 2017 Contact: [email protected] Statement by Ben Wakana, Executive Director of Patients For Affordable Drugs on Prescription Drug Importation Legislation “Patients For Affordable Drugs has one key touchstone in evaluating policy proposals to lower drug prices: In our best judgment, will the proposal help patients access safe and effective drugs at lower costs? “In […]